May 26, 2021 | Publication
Antibodies immunoreactive with formalin-fixed tissue antigens recognize linear protein epitopes
The Latest News from BCS
April 27, 2026
Boston Cell Standards Enters Final Phase of FDA MDDT Program to Qualify First-in-Industry Platform to Standardize Cancer Diagnostic Assays
Continue Reading
January 20, 2026
Boston Cell Standards Calibrator technology presented at The Pathological Society of Great Britain & Ireland Winter Meeting 2026
Continue Reading
January 6, 2026
International study demonstrates the effectiveness of Boston Cell Standards Calibrators for measuring analytical sensitivity used for breast cancer diagnosis.
Continue Reading